BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 18519086)

  • 1. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
    Loonen AJ; Knoers NV; van Os CH; Deen PM
    Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?
    Boone M; Deen PM
    Exp Physiol; 2009 Feb; 94(2):186-90. PubMed ID: 18790812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
    Savelkoul PJ; De Mattia F; Li Y; Kamsteeg EJ; Konings IB; van der Sluijs P; Deen PM
    Hum Mutat; 2009 Oct; 30(10):E891-903. PubMed ID: 19585583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.
    de Mattia F; Savelkoul PJ; Kamsteeg EJ; Konings IB; van der Sluijs P; Mallmann R; Oksche A; Deen PM
    J Am Soc Nephrol; 2005 Oct; 16(10):2872-80. PubMed ID: 16120822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
    van Os CH; Deen PM
    Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.
    de Mattia F; Savelkoul PJ; Bichet DG; Kamsteeg EJ; Konings IB; Marr N; Arthus MF; Lonergan M; van Os CH; van der Sluijs P; Robertson G; Deen PM
    Hum Mol Genet; 2004 Dec; 13(24):3045-56. PubMed ID: 15509592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK; Nielsen S; Kurtz I
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.
    Kamsteeg EJ; Wormhoudt TA; Rijss JP; van Os CH; Deen PM
    EMBO J; 1999 May; 18(9):2394-400. PubMed ID: 10228154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus.
    Kamsteeg EJ; Stoffels M; Tamma G; Konings IB; Deen PM
    Hum Mutat; 2009 Oct; 30(10):1387-96. PubMed ID: 19701945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of aquaporin-2 trafficking.
    Nedvetsky PI; Tamma G; Beulshausen S; Valenti G; Rosenthal W; Klussmann E
    Handb Exp Pharmacol; 2009; (190):133-57. PubMed ID: 19096775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological aspects of water transport in the collecting ducts].
    Bichet DG
    Nephrologie; 1996; 17(7):417-22. PubMed ID: 9019668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion.
    Yang B; Zhao D; Qian L; Verkman AS
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F465-72. PubMed ID: 16434568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG; Turner M; Morin D
    Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.
    Shi PP; Cao XR; Qu J; Volk KA; Kirby P; Williamson RA; Stokes JB; Yang B
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1334-44. PubMed ID: 17229678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.